- Home
- GTX vs DNLI Comparison
GTX vs DNLI Comparison
Compare GTX & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTX
- DNLI
- Stock Information
- Founded
- GTX 2018
- DNLI 2013
- Country
- GTX Switzerland
- DNLI United States
- Employees
- GTX N/A
- DNLI N/A
- Industry
- GTX Auto Parts:O.E.M.
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GTX Consumer Discretionary
- DNLI Health Care
- Exchange
- GTX Nasdaq
- DNLI Nasdaq
- Market Cap
- GTX 1.8B
- DNLI 1.8B
- IPO Year
- GTX N/A
- DNLI 2017
- Fundamental
- Price
- GTX $9.02
- DNLI $12.74
- Analyst Decision
- GTX Strong Buy
- DNLI Strong Buy
- Analyst Count
- GTX 1
- DNLI 16
- Target Price
- GTX $12.00
- DNLI $37.57
- AVG Volume (30 Days)
- GTX 2.0M
- DNLI 1.7M
- Earning Date
- GTX 05-01-2025
- DNLI 05-06-2025
- Dividend Yield
- GTX 0.67%
- DNLI N/A
- EPS Growth
- GTX N/A
- DNLI N/A
- EPS
- GTX 1.26
- DNLI N/A
- Revenue
- GTX $3,475,000,000.00
- DNLI N/A
- Revenue This Year
- GTX N/A
- DNLI N/A
- Revenue Next Year
- GTX $7.85
- DNLI $372.05
- P/E Ratio
- GTX $7.16
- DNLI N/A
- Revenue Growth
- GTX N/A
- DNLI N/A
- 52 Week Low
- GTX $7.02
- DNLI $10.57
- 52 Week High
- GTX $10.39
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- GTX 55.97
- DNLI 42.15
- Support Level
- GTX $8.84
- DNLI $12.37
- Resistance Level
- GTX $9.22
- DNLI $13.63
- Average True Range (ATR)
- GTX 0.46
- DNLI 1.24
- MACD
- GTX 0.14
- DNLI 0.23
- Stochastic Oscillator
- GTX 91.14
- DNLI 50.94
About GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.